These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 15492300

  • 1. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
    Spargias K, Alexopoulos E, Kyrzopoulos S, Iokovis P, Greenwood DC, Manginas A, Voudris V, Pavlides G, Buller CE, Kremastinos D, Cokkinos DV.
    Circulation; 2004 Nov 02; 110(18):2837-42. PubMed ID: 15492300
    [Abstract] [Full Text] [Related]

  • 2. Iloprost prevents contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
    Spargias K, Adreanides E, Demerouti E, Gkouziouta A, Manginas A, Pavlides G, Voudris V, Cokkinos DV.
    Circulation; 2009 Nov 03; 120(18):1793-9. PubMed ID: 19841299
    [Abstract] [Full Text] [Related]

  • 3. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.
    Jo SH, Koo BK, Park JS, Kang HJ, Kim YJ, Kim HL, Chae IH, Choi DJ, Sohn DW, Oh BH, Park YB, Choi YS, Kim HS.
    Am Heart J; 2009 Mar 03; 157(3):576-83. PubMed ID: 19249432
    [Abstract] [Full Text] [Related]

  • 4. Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial.
    Thiele H, Hildebrand L, Schirdewahn C, Eitel I, Adams V, Fuernau G, Erbs S, Linke A, Diederich KW, Nowak M, Desch S, Gutberlet M, Schuler G.
    J Am Coll Cardiol; 2010 May 18; 55(20):2201-9. PubMed ID: 20466200
    [Abstract] [Full Text] [Related]

  • 5. Protection of radiocontrast induced nephropathy by vitamin E (alpha tocopherol): a randomized controlled pilot study.
    Tasanarong A, Piyayotai D, Thitiarchakul S.
    J Med Assoc Thai; 2009 Oct 18; 92(10):1273-81. PubMed ID: 19845233
    [Abstract] [Full Text] [Related]

  • 6. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial.
    Majumdar SR, Kjellstrand CM, Tymchak WJ, Hervas-Malo M, Taylor DA, Teo KK.
    Am J Kidney Dis; 2009 Oct 18; 54(4):602-9. PubMed ID: 19535188
    [Abstract] [Full Text] [Related]

  • 7. Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease.
    Toso A, Maioli M, Leoncini M, Gallopin M, Tedeschi D, Micheletti C, Manzone C, Amato M, Bellandi F.
    Am J Cardiol; 2010 Feb 01; 105(3):288-92. PubMed ID: 20102936
    [Abstract] [Full Text] [Related]

  • 8. Ascorbic Acid for the prevention of contrast-induced nephropathy after coronary angiography in patients with chronic renal impairment: a randomized controlled trial.
    Dvoršak B, Kanič V, Ekart R, Bevc S, Hojs R.
    Ther Apher Dial; 2013 Aug 01; 17(4):384-90. PubMed ID: 23931876
    [Abstract] [Full Text] [Related]

  • 9. Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature.
    Goldenberg I, Shechter M, Matetzky S, Jonas M, Adam M, Pres H, Elian D, Agranat O, Schwammenthal E, Guetta V.
    Eur Heart J; 2004 Feb 01; 25(3):212-8. PubMed ID: 14972421
    [Abstract] [Full Text] [Related]

  • 10. Contrast nephropathy in high-risk patients undergoing coronary angiography and intervention.
    Uddin MA, Rabbani MA, Jafary FH, Bhatti MA, Islam M.
    J Coll Physicians Surg Pak; 2005 Dec 01; 15(12):791-4. PubMed ID: 16398973
    [Abstract] [Full Text] [Related]

  • 11. Post-coronarography application of continuous veno-venous hemofiltration in the prevention of contrast nephropathy in patients with complex multisystem deficiency.
    La Manna G, Pancaldi L, Dalmastri V, Cuna V, Capecchi A, Comai G, Persici E, Bacchi G, Cianciolo G, Lombardi A, Marrozzini C, Colì L, Stefoni S.
    In Vivo; 2008 Dec 01; 22(1):123-9. PubMed ID: 18396794
    [Abstract] [Full Text] [Related]

  • 12. Prophylaxis of contrast-induced nephropathy in patients undergoing coronary angiography.
    MacNeill BD, Harding SA, Bazari H, Patton KK, Colon-Hernadez P, DeJoseph D, Jang IK.
    Catheter Cardiovasc Interv; 2003 Dec 01; 60(4):458-61. PubMed ID: 14624421
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of N-acetylcysteine and hydration versus placebo and hydration in decreasing contrast-induced renal dysfunction in patients undergoing coronary angiography with or without concomitant percutaneous coronary intervention.
    Seyon RA, Jensen LA, Ferguson IA, Williams RG.
    Heart Lung; 2007 Dec 01; 36(3):195-204. PubMed ID: 17509426
    [Abstract] [Full Text] [Related]

  • 14. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
    Brueck M, Cengiz H, Hoeltgen R, Wieczorek M, Boedeker RH, Scheibelhut C, Boening A.
    J Invasive Cardiol; 2013 Jun 01; 25(6):276-83. PubMed ID: 23735352
    [Abstract] [Full Text] [Related]

  • 15. Role of probucol in preventing contrast-induced acute kidney injury after coronary interventional procedure.
    Li G, Yin L, Liu T, Zheng X, Xu G, Xu Y, Yuan R, Che J, Liu H, Zhou L, Chen X, He M, Li Y, Wu L, Liu E.
    Am J Cardiol; 2009 Feb 15; 103(4):512-4. PubMed ID: 19195512
    [Abstract] [Full Text] [Related]

  • 16. Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Xinwei J, Xianghua F, Jing Z, Xinshun G, Ling X, Weize F, Guozhen H, Yunfa J, Weili W, Shiqiang L.
    Am J Cardiol; 2009 Aug 15; 104(4):519-24. PubMed ID: 19660605
    [Abstract] [Full Text] [Related]

  • 17. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
    Oldemeyer JB, Biddle WP, Wurdeman RL, Mooss AN, Cichowski E, Hilleman DE.
    Am Heart J; 2003 Dec 15; 146(6):E23. PubMed ID: 14661012
    [Abstract] [Full Text] [Related]

  • 18. Reno-protective effect of N-acetyl cysteine in patients with impaired renal function undergoing coronary angiography and interventions.
    Ramesh N, Pillai RK, Abraham T, Padmaja NP, Hameed S, Vijayaraghavan G.
    J Assoc Physicians India; 2006 Jun 15; 54():449-52. PubMed ID: 16909692
    [Abstract] [Full Text] [Related]

  • 19. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.
    Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W.
    N Engl J Med; 2000 Jul 20; 343(3):180-4. PubMed ID: 10900277
    [Abstract] [Full Text] [Related]

  • 20. Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure.
    Masuda M, Yamada T, Mine T, Morita T, Tamaki S, Tsukamoto Y, Okuda K, Iwasaki Y, Hori M, Fukunami M.
    Am J Cardiol; 2007 Sep 01; 100(5):781-6. PubMed ID: 17719320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.